Cardlytics, Inc. (CDLX): M&A transaction — Cardlytics completes sale of Bridg platform to PAR Technology for 1.81M PAR shares

Cardlytics, Inc.

Closed Bridg asset sale to PAR on March 24, 2026; consideration of 1,810,222 shares of PAR common stock.
Pro forma 2025 revenue of $212.3M (Bridg contributed $20.9M); pro forma net loss $91.5M vs historical $103.5M.
Pro forma 2024 net loss improves to $40.4M from $189.3M, largely due to removal of Bridg goodwill impairment.
Estimated gain on sale of $13.9M (after $1.6M transaction costs) to be recorded in Q1 2026.
Bridg discontinued operations for all periods; pro forma adjusted EPS for 2025: -$1.72 vs -$1.95 reported.

item 2.01 item 1.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Cardlytics, Inc. completed a disposition involving PAR Technology Corporation (closed 2026-03-24).

Action: disposition
Counterparty: PAR Technology Corporation
Closing: 2026-03-24

Exact text from the filing

On March 24, 2026 (the “Closing Date”), the Company, PAR and Buyer completed the Bridg Sale.

View on SEC.gov

Browse all m&a transactions →

Cardlytics, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-020811

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.